Viewing Study NCT02311361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:02 PM
Ignite Modification Date: 2026-01-28 @ 8:31 AM
Study NCT ID: NCT02311361
Status: COMPLETED
Last Update Posted: 2021-04-20
First Post: 2014-12-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Neoplasms View
None Pancreatic Cancer View
None Cancer of Pancreas View
None Cancer of the Pancreas View
None Pancreas Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-PDL1 View
None Anti-CTLA4 View
None Streostatic Body Radiation Therapy (SBRT) View
None Monoclonal Antibody View
None Antitumor Immunity View